Literature DB >> 7898383

Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.

A Yasuoka1, S Kohno, H Yamada, M Kaku, H Koga.   

Abstract

The role of capsular polysaccharides (CPS) of Cryptococcus neoformans in phagocytosis by murine alveolar macrophages was investigated in four strains of C. neoformans serotype A, YC-11, YC-5, YC-27 and YC-13. Phagocytosis rates increased markedly after adding 10% mouse serum, compared to fetal calf serum. The reverse relation between capsular thickness of C. neoformans and phagocytosis by alveolar macrophages was observed except in YC-27, which had thin capsules and high virulence. The phagocytosis rate in mice serum was 17.3% in YC-11 (capsule thickness 2.8-3.5 microns), 39.8% in YC-5 (capsule size 0.8-1.5 microns), 20.3% in YC-27 (capsule size 0.6-1.1 microns), and 62.8% in YC-13 (capsule not detected microscopically). The CPS of YC-11, YC-5, and YC-27 analyzed by gel-filtration using CL-2B showed high molecular fractions near the void volume. However, the CPS of YC-13 showed only low molecular fractions. The widely eluted CPS of YC-11 was separated into 3 fractions and each fraction was added in the phagocytosis assay of YC-13. Phagocytosis was markedly suppressed particularly by the addition of a higher molecular fraction. These results suggest that phagocytosis of C. neoformans by alveolar macrophages is influenced by the molecular sizes of the CPS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898383     DOI: 10.1111/j.1348-0421.1994.tb02137.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time.

Authors:  N T Gross; M Chinchilla; P Camner; C Jarstrand
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Toll-like receptor 9-dependent activation of bone marrow-derived dendritic cells by URA5 DNA from Cryptococcus neoformans.

Authors:  Misuzu Tanaka; Keiko Ishii; Yuri Nakamura; Akiko Miyazato; Atsuko Maki; Yuzuru Abe; Tomomitsu Miyasaka; Hideki Yamamoto; Yukiko Akahori; Misaki Fue; Yurie Takahashi; Emi Kanno; Ryoko Maruyama; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

3.  Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.

Authors:  K Kawakami; Y Kinjo; S Yara; K Uezu; Y Koguchi; M Tohyama; M Azuma; K Takeda; S Akira; A Saito
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.

Authors:  K Kawakami; Y Kinjo; S Yara; Y Koguchi; K Uezu; T Nakayama; M Taniguchi; A Saito
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans.

Authors:  C A D'Souza; J A Alspaugh; C Yue; T Harashima; G M Cox; J R Perfect; J Heitman
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.

Authors:  Tiffany Guess; Hoyin Lai; Serenah E Smith; Linda Sircy; Kirsten Cunningham; David E Nelson; Erin E McClelland
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

8.  CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Authors:  Mairi C Noverr; Peter R Williamson; Ryan S Fajardo; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 9.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

10.  Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations.

Authors:  J D Nosanchuk; W Cleare; S P Franzot; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.